Freedom of Information Request: 0370 2019/20
Within your trust how many of the following intra-vitreal vials/implants have been used in the latest 4 months, if possible between May to August 2019;
Aflibercept | 1729 |
Bevacizumab | 191 |
Dexamethasone | 107 |
Fluocinolone | 4 |
Ranibizumab | 1802 |